Skip to main content

PetMed Express, Inc.

corporate_fare Company Profile

PetMed Express, Inc.

PETS·NASDAQ·Trade & Services·CIK 0001040130

PetMed Express Inc. operates as a direct-to-consumer pet health and wellness retailer, doing business as PetMeds and as the parent company of PetCareRx. Established in 1996, the company markets and sells products directly to consumers via its websites (Petmeds.com and PetCareRx.com), customer contact centers, and mobile applications (iOS and Android). PetMed Express Inc. provides access to top branded pharmaceuticals, generic medications, compounded prescription medications, and over-the-counter (OTC) health and wellness products. The company also offers prescription and non-prescription food, pharmacy fulfillment services, and personalized AutoShip capabilities. Its digital platform delivers pet healthcare solutions for various chronic conditions, including allergies, arthritis, anxiety, kidney issues, and hyperthyroidism, for cats, dogs, and horses. Additionally, the company provides a range of non-prescription health and wellness products, Rx food, non-Rx food, and treats. PetMeds and PetCareRx process pet orders received through their websites and mobile applications and coordinate with the customer's licensed veterinarian for prescription approval. Through its content website, pethealthmd.com, consumers can access educational articles on pet health. The company has fulfilled orders for almost twenty-million pet parents across all 50 states since its founding 30 years ago.

PetMed Express, Inc. (NASDAQ:PETS) is a publicly traded company in the Trade & Services sector. Wiseek monitors PETS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • PetMed Express Unlocks $37M in Cash Through HQ Sale-Leaseback Amid Going-Concern Fears
  • PetMed Express Confirms Receipt of SilverCape's $3.00/Share Acquisition Proposal
  • PetMed Express Shares Surge on SilverCape's Revised $3/Share Buyout Offer
  • Activist Investor SilverCape Proposes $3.00/Share Cash Take-Private for PetMed Express
  • PetMed Express Seeks Shareholder Approval for 8% Equity Plan Dilution Amid Going Concern Warning

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$179.02M
Net Income
-$57.29M
Diluted EPS
-$2.74
Op. Cash Flow
-$28.39M
Free Cash Flow
-$33.01M
Gross Profit
$50.22M
Operating Income
-$58.67M
Cash & Equivalents
$21.41M
Debt / Equity
0.00×
Net Margin
-32.0%
Shares Outstanding
21.39M sh
Source: 10-K · filed 2026-06-02 · accession 0001040130-26-000019
Browse all tickers starting with P →
$1.97
52-week range · as of 2026-07-23 $1.57 – $4.1
Market cap
$42.96M
Volume
114.3K (0.1× avg)
3-mo avg 1.2M
Live data · 2026-07-29 09:31 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed PETS - Latest Insights

PETS
Jul 23, 2026, 9:26 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.09
Real-time Price: $1.97 info
Change: -$0.1169 (-6%) info
Market Cap: $42.957M info
PETS
Jun 30, 2026, 9:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1.78
Real-time Price: $1.97 info
Change: +$0.190 (+11%) info
Market Cap: $42.957M info
PETS
Jun 29, 2026, 10:16 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $2.19
Real-time Price: $1.97 info
Change: -$0.215 (-10%) info
Market Cap: $42.957M info
PETS
Jun 29, 2026, 7:36 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $1.79
Real-time Price: $1.97 info
Change: +$0.180 (+10%) info
Market Cap: $42.957M info
PETS
Jun 25, 2026, 4:19 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $1.77
Real-time Price: $1.97 info
Change: +$0.200 (+11%) info
Market Cap: $42.957M info
PETS
Jun 03, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.02
Real-time Price: $1.97 info
Change: -$0.0471 (-2%) info
Market Cap: $42.957M info
PETS
Jun 02, 2026, 4:55 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.95
Real-time Price: $1.97 info
Change: +$0.0184 (+0.94%) info
Market Cap: $42.957M info
PETS
Jun 02, 2026, 4:17 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.13
Real-time Price: $1.97 info
Change: -$0.1591 (-7%) info
Market Cap: $42.957M info
PETS
Jun 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.12
Real-time Price: $1.97 info
Change: -$0.150 (-7%) info
Market Cap: $42.957M info
PETS
Jun 02, 2026, 4:06 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.20
Real-time Price: $1.97 info
Change: -$0.2296 (-10%) info
Market Cap: $42.957M info
PETS
May 29, 2026, 4:02 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.17
Real-time Price: $1.97 info
Change: -$0.200 (-9%) info
Market Cap: $42.957M info
PETS
Apr 22, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.34
Real-time Price: $1.97 info
Change: -$0.370 (-16%) info
Market Cap: $42.957M info
PETS
Feb 11, 2026, 9:45 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $2.98
Real-time Price: $1.97 info
Change: -$1.01 (-34%) info
Market Cap: $42.957M info
PETS
Feb 05, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.98
Real-time Price: $1.97 info
Change: -$1.01 (-34%) info
Market Cap: $42.957M info